Drug combination prompts immune response in some resistant pancreatic cancers

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup